This country profile provides an overview of South Africa’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
South Africa does not require mass treatment for elephantiasis.
South Africa does not require mass treatment for blinding trachoma.
Treatment coverage decreased 54% in 2018 to 14% in 2019.
Treatment coverage remained at 0% in 2018 and 2019.
South Africa does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in South Africa.